Le Lézard
Classified in: Health
Subjects: VET, MAT, DEI

Delta 8 THC is Helping Veterans in Many Ways

INDIANAPOLIS, Nov. 11, 2021 /PRNewswire/ -- For veterans with PTSD, chronic pain, anxiety, and more, life can seem overwhelming sometimes. One thing that has helped many veterans cope with their symptoms is medical cannabis. But the Department of Veteran Affairs (VA) hasn't made things easy for veterans to get the help they need. This has led many to choose a safe and legal alternative called Delta 8.

Veterans appreciate the use of Delta 8 for its potential advantages, affordability and legality.

Delta 8 is a federally legal cannabinoid which offers similar effects to medical cannabis without some of the unwanted side effects of cannabis, which contains Delta 9. Delta 9 is known to be more intoxicating than Delta 8, and it can cause an increase in paranoia and anxiety, along with confusion and a clouded head for some. Consumers, including veterans, have said Delta 8 doesn't have the unwanted side effects while also helping them with their anxiety, PTSD, and chronic pain. 

Additionally, several veterans have reported they have an improved quality of life. They are experiencing less pain. Plus, those who take Delta 8 also say they have been able to reduce the amount of opioids they take with the help and guidance of their doctor. Recent studies have shown the same benefits of cannabis. Consumers are using more cannabis and medical cannabis over opioids, leading to less addiction and dependence on opioids during a countrywide epidemic.

Even though the VA says they are still looking into the potential benefit of cannabis for military veterans with PTSD, federal lawmakers are moving things forward. Most recently, House and Senate subcommittees both approved research efforts requiring the VA to take action. A key will be research on medical cannabis for PTSD veterans as a potential alternative to opioids.

In the meantime, veterans appreciate the use of Delta 8 for its potential advantages, affordability and legality. 

3Chi is a pioneer in science-based cannabis research and was the first commercial developer of hemp-derived Delta-8 THC. Based in Indiana, the company continues today as an industry leader in emerging cannabis science and innovative hemp-derived products. To learn more, click here: 3Chi.com

For questions and media inquiries, please reach out to: [email protected]


These press releases may also interest you

at 10:41
"Hate always terrorizes. That's the intention. As an African American woman who came of age during the Civil Rights era, I know at heart how hate works to harm some and paralyze or, at least, to immobilize others. But movement is life. It's certainly...

at 10:30
The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course" conference has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition...

at 10:30
Najah Sampson has been named President of Pfizer Canada ULC, effective May 16, 2022. Ms. Sampson will be succeeding Cole Pinnow, who...

at 10:30
The global Ibuprofen API Market surpassed US$ 626.2 Mn in 2022 and is anticipated to increase at a CAGR of 3% to reach US$ 772.2 Mn by 2029. as per the findings of a...

at 10:30
The "Hospital Lights Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Technology and Application" report has been added to ResearchAndMarkets.com's offering. The Hospital Lights market is expected to grow from US$...

at 10:20
The Cryogenic PPE Market size is expected to grow by USD 426.23 million from 2021 to 2026, at a CAGR of 6.52% during the forecast period. The expanding applications in healthcare and life sciences is one of the primary aspects driving the cryogenic...

News published on 11 november 2021 at 15:43 and distributed by: